Federal Register #DEA-1791

DEA review of Noramco controlled-substance importer registration application

The Drug Enforcement Administration is reviewing Noramco’s application to register as an importer of controlled substances. - Government buyer/agency: Drug Enforcement Administration (DEA), U.S. Department of Justice. This is a regulatory notice, not a procurement solicitation. - Applicant and manufacturer: Noramco proposes imports for bulk manufacturing; no other vendors or OEMs are named. - Substances listed in the application: - Schedule I: gamma hydroxybutyric acid (drug code 2010), marihuana (7360), and tetrahydrocannabinols (7370). - Schedule II: methadone-intermediate (9254); raw opium (9600); opium extracts (9610); opium fluid extract (9620); opium tincture (9630); powdered opium (9639); granulated opium (9640); opium poppy/poppy straw (9650); noroxymorphone (9668); poppy straw concentrate (9670); and tapentadol (9780). - Proposed import purposes: Poppy straw concentrate for bulk manufacture of other controlled substances; an intermediate form of tapentadol for bulk manufacture of tapentadol; and synthetic cannabidiol and synthetic tetrahydrocannabinol. - Scope limitation: The proposed registration would not authorize other activities for the listed drug codes or imports of finished dosage forms for commercial sale. - Quantities and part numbers: None specified. No product or service line items are being solicited.

Description

Noramco applied to the Drug Enforcement Administration to be registered as an importer of basic classes of controlled substances. The application covers multiple listed controlled substances, including Poppy Straw Concentrate, an intermediate form of Tapentadol, synthetic cannabidiol, and synthetic Tetrahydrocannabinol. The company plans to import certain substances for bulk manufacture and distribution to customers. Eligible parties may submit comments or objections, or request a hearing, by December 7, 2026.

View original listing